AzTrials
AzTrials

Limbs ArthrosisHYPTENSNCT01944150

Association of Transcutaneous Electrical Nerve Stimulation and Hypnosis

A study testing Transcutaneous electrical nerve stimulation and Transcutaneous electrical nerve stimulation and hypnosis in people with Limbs Arthrosis and Non Arthrosic Limbs Arthralgia, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

At Saint-Antoine's hospital, in CETD a multidisciplinary team takes care of patients with chronic pain. Free-drug techniques are available to reduce their consumption of analgesics. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Transcutaneous electrical nerve stimulation and Transcutaneous electrical nerve stimulation and hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteFrance
Study dates
Sep 2013to May 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients from 18 to 80 years suffering from chronic no cancer pain either nociceptive or neuropathic.
  • The treated skin must not be wounded
  • The patients must be able to comply with the requirement of the trial; they also need to express no objection to participate to this trial.
  • Patient with social security

Who cannot join

  • Patients with fibromyalgia, or having relaxation therapy sessions, acupuncture, cognitive and behavioral therapies
  • Patients with cognitive disorders, an unaided hearing loss, a major hearing impairment, carrying a pace maker, having an allodynia or a complete anesthesia of the painful territory, a large spreader painful territory
  • Sessions TENS practiced for analgesic by a professional within 3 years prior to inclusion, for the same pain (same features, same location)
  • Renting at home a TENS device within 3 years prior to inclusion for analgesic
  • Prior therapeutic care by hypnosis
  • pregnant woman or having a desire of pregnancy

Trial locations and contacts

1 site in 1 country.

France1 site
  • CETD - Hospital Saint-Antoine

    Paris, 75012

Other trials in France

About this study

Official title: Interest of the Association of Two Complementary Techniques, Hypnosis and Transcutaneous Electrical Nerve Stimulation in the Treatment of Chronic Non-cancer Pain, Nociceptive and / or Neuropathic Pain: Randomized Trial

At Saint-Antoine's hospital, in CETD a multidisciplinary team takes care of patients with chronic pain. Free-drug techniques are available to reduce their consumption of analgesics. This study is to assess the relief obtained by the simultaneous combination of these two techniques: transcutaneous electrical nerve stimulation and hypnosis.

Read the detailed description

In the pain management centers, patients with chronic pain are supported by a multidisciplinary team. To optimize and reduce drug intake of analgesics, additional techniques (hypnosis, relaxation, cognitive behavioral therapy) and non-drug practices (transcutaneous electrical nerve stimulation) are offered to patients.

These techniques are most frequently performed by nurses and are used either separately or successively. The time interval during what the patient could expect pain relief is not known.

The hypothesis of the study is that simultaneous practice of two complementary therapies (transcutaneous electrical nerve stimulation (TENS) + hypnosis) decreases the intensity of pain in patients with chronic no cancer pain, nociceptive and/or neuropathic pain compared to practice of only one complementary therapy (TENS).

This study is an open randomized trial, comparative in two parallel groups (TENS versus TENS and hypnosis).

Trial design will be explained by the pain management center doctor. Inclusion and randomization performed by the nurse: group with TENS/group with TENS and hypnosis.

The patients will be followed up 8 times between day 0 and day180. Patients benefit from eight visits from day 0th to day 180th. Evaluations are EVA at each visit, SF36 questionnaires and score PGIC at one month, three and six months after the beginning of the strategy.

Being tested
Transcutaneous electrical nerve stimulation, Transcutaneous electrical nerve stimulation and hypnosis
Keywords
Hypnosis, chronic pain, transcutaneous electrical nerve stimulation, nociceptive pain, neuropathic pain, complementary therapies
Medical subject headings
Radiculopathy, Neuralgia, Postherpetic, Complex Regional Pain Syndromes, Tendinopathy, Chronic Pain, Nociceptive Pain, Neuralgia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcutaneous electrical nerve stimulationBehavioural

    explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse during 30 minutes lasting session

  • Transcutaneous electrical nerve stimulation and hypnosisBehavioural

    explanations about devices and their use are given to the patient during the first session. The right place where the electrodes should be placed on, the most effective programme (optimal electric frequency provided by the machine), intensity are tested by the nurse. Following informations are collected by the second nurse: pain representation and its relief thoughts about a quiet place. TENS and hypnosis are associated in a unique 30 minutes session

Study groups in NCT01944150
Study groupRoleWhat they receive
TENSActive comparatorPatients with only transcutaneous electrical nerve stimulation (TENS),
Receives: Behavioral: Transcutaneous electrical nerve stimulation
TENS and hypnosis.ExperimentalPatients with transcutaneous electrical nerve stimulation (TENS) and hypnosis simultaneously
Receives: Behavioral: Transcutaneous electrical nerve stimulation and hypnosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    The pain assessment is processed using a Visual Analog Scale (VAS), graduated from 0 to 100mm.

    The patient is asked to move a cursor on a line to reflect the severity of his/her pain. The left end indicates "no pain", the right one shows "the most intense pain you can imagine".

    On the other side, graduations are only seen by the caregiver. The pain intensity is read on this side, rated in millimetres.

    Measured: between the first visit and three months after the beginning of the strategy.

Secondary outcomes (3)
  1. the patient's observance with the different strategies using a pad.

    Collections of the data (number and duration of TENS device uses) from the patient log book

    Measured: from one week after the beginning of the strategy up to 6 months.

  2. the consumption of analgesic

    Collection of the concomitant treatments (processing) on the patient pad in every visit.

    Measured: during 6 months.

  3. the quality of life estimated by the patient using the scale(ladder) SF36 and estimating the impression(printing) of change of the patient using the PGIC scale(ladder)

    These two scales are self-assessment, exploring physical, emotional and social health.

    They allow pain impact assessment or professional activities, leisure activities and everyday life.

    The final aim is to identify if patients could recover their usual activity faster in one arm of the study versus the other one.

    Measured: at the first visit, one month, three and six months after the beginning of the strategy, except the scale QDSA, which is used one, three and six months later after the beginning of the strategy.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2013 (estimated)
  2. Study startSep 2013
  3. Primary completionFeb 2017
  4. Study completionMay 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01944150
Sponsor's protocol ID
K121201
Other IDs
PHRI120049
Acronym
HYPTENS
Status last verified
Aug 2017
First submitted
2 Sep 2013
Last updated
3 Aug 2017
Results posted
No
Data monitoring committee
No

Publications

  • Smart KM, Ferraro MC, Wand BM, O'Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev. 2022 May 17;5(5):CD010853. doi: 10.1002/14651858.CD010853.pub3.

    PubMed 35579382
  • Tonye-Geoffroy L, Mauboussin Carlos S, Tuffet S, Fromentin H, Berard L, Leblanc J, Laroche F. Efficacy of a combination of hypnosis and transcutaneous electrical nerve stimulation for chronic non-cancer pain: A randomized controlled trial. J Adv Nurs. 2021 Jun;77(6):2875-2886. doi: 10.1111/jan.14833. Epub 2021 Mar 30.

    PubMed 33783846

Questions about this trial

What is this clinical trial studying?

A study testing Transcutaneous electrical nerve stimulation and Transcutaneous electrical nerve stimulation and hypnosis in people with Limbs Arthrosis and Non Arthrosic Limbs Arthralgia, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: between the first visit and three months after the beginning of the strategy.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01944150, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in